The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin

Published:2013-03 Issue:9 Volume:34 Page:2277-2288
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Fan Yuchen,Du Wenwen,He Bing,Fu Fengying,Yuan Lan,Wu Hounan,Dai Wenbing,Zhang Hua,Wang Xueqing,Wang Jiancheng,Zhang Xuan,Zhang Qiang

Funder

National Natural Science Foundation of China

National Research Fund for Fundamental Key Project

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference41 articles.

1. High interstitial fluid pressure - an obstacle in cancer therapy;Heldin;Nat Rev Cancer,2004

2. Delivering nanomedicine to solid tumors;Jain;Nat Rev Clin Oncol,2010

3. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis;Lunt;Future Oncol,2008

4. Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics;Ferretti;Neoplasia,2009

5. Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells;Zhang;Biomaterials,2012

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boosting Checkpoint Immunotherapy with Biomimetic Nanodrug Delivery Systems;Advanced Healthcare Materials;2024-02-15

2. Computational Multi-Scale Modeling of Drug Delivery into an Anti-Angiogenic Therapy-Treated Tumor;Cancers;2023-11-17

3. Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine;Oncogene;2023-10-20

4. Integration of an LPAR1 Antagonist into Liposomes Enhances Their Internalization and Tumor Accumulation in an Animal Model of Human Metastatic Breast Cancer;Molecular Pharmaceutics;2023-10-16

5. Induced Vascular Normalization—Can One Force Tumors to Surrender to a Better Microenvironment?;Pharmaceutics;2023-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3